Dimensional Fund Advisors LP grew its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,794,086 shares of the company's stock after purchasing an additional 102,109 shares during the quarter. Dimensional Fund Advisors LP owned about 0.70% of Corteva worth $273,062,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Independent Franchise Partners LLP lifted its stake in Corteva by 51.5% in the fourth quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock valued at $939,641,000 after buying an additional 5,604,838 shares during the period. Norges Bank acquired a new position in shares of Corteva during the 4th quarter valued at $251,892,000. Raymond James Financial Inc. bought a new position in Corteva during the fourth quarter worth $161,052,000. Franklin Resources Inc. grew its holdings in Corteva by 9.2% in the fourth quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock worth $919,507,000 after purchasing an additional 1,354,418 shares during the period. Finally, B. Metzler seel. Sohn & Co. AG boosted its holdings in Corteva by 69.0% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 2,870,859 shares of the company's stock worth $163,181,000 after acquiring an additional 1,172,110 shares in the last quarter. 81.54% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages have commented on CTVA. Bank of America boosted their price target on shares of Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. Argus raised shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price objective on the stock in a research report on Monday, March 31st. UBS Group lowered their price target on shares of Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. The Goldman Sachs Group started coverage on Corteva in a research report on Thursday, March 13th. They set a "buy" rating and a $71.00 price target on the stock. Finally, BNP Paribas raised Corteva to a "hold" rating in a report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Corteva has an average rating of "Moderate Buy" and an average price target of $68.13.
Get Our Latest Stock Report on CTVA
Insider Transactions at Corteva
In other news, insider Brian Titus sold 26,560 shares of the firm's stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.14% of the company's stock.
Corteva Price Performance
Shares of CTVA stock traded down $0.21 during trading on Friday, hitting $61.50. The company had a trading volume of 1,803,138 shares, compared to its average volume of 3,314,685. Corteva, Inc. has a 52 week low of $50.01 and a 52 week high of $66.24. The stock has a market capitalization of $42.01 billion, a price-to-earnings ratio of 47.67, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock's 50-day moving average is $60.77 and its two-hundred day moving average is $60.35.
Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.11%. Corteva's dividend payout ratio (DPR) is currently 52.71%.
Corteva Company Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.